These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 27701095)
1. A painstaking overhaul for cardiac safety testing. Servick K Science; 2016 Sep; 353(6303):976-977. PubMed ID: 27701095 [No Abstract] [Full Text] [Related]
2. Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models. Kraushaar U; Meyer T; Hess D; Gepstein L; Mummery CL; Braam SR; Guenther E Expert Opin Drug Saf; 2012 Mar; 11(2):285-98. PubMed ID: 22103746 [TBL] [Abstract][Full Text] [Related]
3. Ion channel profiling to advance drug discovery and development. Zou B Drug Discov Today Technol; 2015 Nov; 18():18-23. PubMed ID: 26723888 [TBL] [Abstract][Full Text] [Related]
4. Human pluripotent stem cell-derived cardiomyocyte based models for cardiotoxicity and drug discovery. Zhao Y; Korolj A; Feric N; Radisic M Expert Opin Drug Saf; 2016 Nov; 15(11):1455-1458. PubMed ID: 27560951 [No Abstract] [Full Text] [Related]
5. Predicting Drug Safety and Communicating Risk: Benefits of a Bayesian Approach. Lazic SE; Edmunds N; Pollard CE Toxicol Sci; 2018 Mar; 162(1):89-98. PubMed ID: 29126124 [TBL] [Abstract][Full Text] [Related]
7. Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening? Towart R; Linders JT; Hermans AN; Rohrbacher J; van der Linde HJ; Ercken M; Cik M; Roevens P; Teisman A; Gallacher DJ J Pharmacol Toxicol Methods; 2009; 60(1):1-10. PubMed ID: 19439185 [TBL] [Abstract][Full Text] [Related]
8. Functional cardiomyocytes from human stem cells: a tool for determining the cardiotoxic potential of preclinical drugs. Zeevi-Levin N; Itskovitz-Eldor J; Binah O Future Med Chem; 2013 Mar; 5(4):363-6. PubMed ID: 23495680 [No Abstract] [Full Text] [Related]
10. Comprehensive in vitro Proarrhythmia Assay, a novel in vitro/in silico paradigm to detect ventricular proarrhythmic liability: a visionary 21st century initiative. Cavero I; Holzgrefe H Expert Opin Drug Saf; 2014 Jun; 13(6):745-58. PubMed ID: 24845945 [TBL] [Abstract][Full Text] [Related]
11. Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay. Qu Y; Gao B; Fang M; Vargas HM J Pharmacol Toxicol Methods; 2013; 68(1):74-81. PubMed ID: 23518063 [TBL] [Abstract][Full Text] [Related]